PubMed Dalmasso, G., Charrier-Hisamuddin, L., Nguyen, H.T., Yan, Y., Sitaraman, S., Merlin, D
Future FDA action may likewise be specific rather than universal
The extensive preclinical research documenting the mechanisms, effects, and safety profiles of GHK-Cu, BPC-157, and TB-500 establishes a robust scientific foundation for their combined use in laboratory applications, while ongoing research into peptide combinations, advanced delivery systems, and tissue engineering applications continues to expand potential investigational contexts
Wound Repair and Regeneration, 11(1), 19-24
Where Human Evidence Is Still Limited Human evidence is limited for injectable GHK-Cu, systemic anti-aging, hair loss treatment, chronic disease treatment, liver repair, cognitive benefit, and broad regenerative medicine claims
(2014) 9:e107421